ArticleFrontiers in immunology2026

Therapeutic hepatitis B vaccine employing DNA prime - MVA boost scheme requires additional priming with recombinant HBsAg to elicit an adequate antibody response.

Hélène A Kerth et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.